Company Overview of ScarX Therapeutics
ScarX Therapeutics, a pre-clinical stage biotechnology company, engages in the development of a therapeutic as the patient-administered prescription medication for the prophylaxis of dermal scarring in post-surgical wound closures. It develops MI-001 as an anti-scarring agent. The company is based in Toronto, Canada.
Key Executives for ScarX Therapeutics
ScarX Therapeutics Key Developments
Similar Private Companies By Industry
|Hemax Genome, Inc.||Americas|
|Alpha Cancer Technologies Inc.||Americas|
|Genova Biotherapeutics, Inc.||Americas|
|Generex Pharmaceuticals Inc.||Americas|
|Portable Health Intelligence Inc.||Americas|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact ScarX Therapeutics, please visit www.scarxtherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.